Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;47(3):672-676.
doi: 10.1038/s41440-023-01476-8. Epub 2023 Oct 23.

The association between the estimated glomerular filtration rate and cognitive impairment: the Suita Study

Affiliations

The association between the estimated glomerular filtration rate and cognitive impairment: the Suita Study

Ahmed Arafa et al. Hypertens Res. 2024 Mar.

Abstract

This cross-sectional study investigated the association between the estimated glomerular filtration rate (eGFR), a measure of chronic kidney disease (CKD), and cognitive impairment. We used data from 6215 Japanese individuals registered in the Suita Study. Cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score of ≤ 26. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of cognitive impairment for eGFR 45-59.9 and < 45 mL/min/1.73 m2 (mild and moderate-to-severe eGFR reductions) compared to eGFR ≥ 60 mL/min/1.73 m2 (normal eGFR). The results showed that both mild and moderate-to-severe eGFR reductions were associated with cognitive impairment: ORs (95% CIs) = 1.49 (1.22-1.83) and 2.35 (1.69-3.26), respectively (p-trend < 0.001). Each increment of eGFR by 10 mL/min/1.73m2 was associated with 4.8% lower odds of cognitive impairment. In conclusion, eGFR reduction was associated with cognitive impairment. Managing CKD is essential for preventing cognitive impairment.

Keywords: Chronic kidney disease; Cognitive impairment; Estimated glomerular filtration rate; Japan.

PubMed Disclaimer

Comment in

References

    1. Nakahori N, Sekine M, Yamada M, Tatsuse T, Kido H, Suzuki M. Future projections of the prevalence of dementia in Japan: results from the Toyama Dementia Survey. BMC Geriatr. 2021;21:602. - DOI - PubMed - PMC
    1. Montero-Odasso M, Ismail Z, Livingston G. One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case “for” and “against”. Alzheimers Res Ther. 2020;12:81. - DOI - PubMed - PMC
    1. Umebayashi R, Uchida HA, Matsuoka-Uchiyama N, Sugiyama H, Wada J. Prevalence of chronic kidney disease and variation of its risk factors by the Regions in Okayama Prefecture. J Pers Med. 2022;12:97. - DOI - PubMed - PMC
    1. Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74:782–90. - DOI - PubMed - PMC
    1. Deckers K, Camerino I, van Boxtel MP, Verhey FR, Irving K, Brayne C, et al. Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies. Neurology. 2017;88:198–208. - DOI - PubMed - PMC

MeSH terms